A South Korean lettuce variety called heukharang or black harang, which serves as a natural treatment for insomnia is set for cultivation in Australia.
Jeollanamdo Agricultural Research & Extension Services (JARES) developed heukharang, which contains 3.74 milligrams of sleep-inducing lactucin per gram, or 124 times more than regular lettuce.
As the lactucin in regular lettuce is not potent enough to counter insomnia, an adult weighing 60 kilograms would need to consume 4 kilograms of it to induce sleep.
Heukharang would require much less consumption to achieve the desired results.
According to JARES, the Korean chemical firm Isu Chemical Co. has agreed to produce and sell heukharang lettuce in Australia.
Since Australia has strict quarantine laws for imported food but allows the importation of seeds, Isu Chemical Co. has to cultivate heukharang in Australia.
With its high gross national income and high prevalence of adult sleep disorders., Australia is a promising market for high-value-added and functional vegetables like heukharang.
Meanwhile. South Korea's market for insomnia treatment was estimated to be worth 40 billion won in 2020 and has been expanding at more than 5 percent annually.


BoE Set to Cut Rates as UK Inflation Slows, but Further Easing Likely Limited
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Japan Inflation Holds Firm in November as BOJ Nears Key Rate Hike Decision
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Oil Prices Climb on Venezuela Blockade, Russia Sanctions Fears, and Supply Risks
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 



